POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.
High Impact

Senate Hearing on Alzheimer's Disease and Medicare Impact

Original title: ALZHEIMER'S DISEASE: THE STRUGGLE FOR FAMILIES, A LOOMING CRISIS FOR MEDICARE

Record date · January 1, 2017

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This Senate Subcommittee on Health Care hearing examined the medical and financial challenges posed by Alzheimer's disease. Witnesses and senators discussed the disease's status as a leading cause of death and its significant economic impact on the and programs.

Why it matters

The hearing highlights the fiscal strain Alzheimer's disease places on federal healthcare programs, as patients with the condition account for 20 percent of all spending despite representing only 10 percent of beneficiaries.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Medicare beneficiaries with Alzheimer's

These individuals are the primary subjects of the medical and financial data discussed regarding care costs and disease progression.

Directly affected

Family caregivers

Caregivers face emotional and financial burdens associated with providing care for individuals with Alzheimer's.

Key Facts

  • Approximately 5.2 million Americans are estimated to have Alzheimer's disease.
  • Alzheimer's disease is the sixth leading cause of death in the United States.
  • Medicare and Medicaid combined spend over $160 billion annually on Alzheimer's care.
  • Patients with Alzheimer's represent 10 percent of Medicare beneficiaries but account for 20 percent of total Medicare spending.
Show all 5 facts
  • There is currently no known cure or treatment for Alzheimer's disease.

Frequently Asked Questions

How many people in the U.S. have Alzheimer's?
It is estimated that 5.2 million Americans are living with the disease.
What is the financial impact of Alzheimer's on Medicare?
While Alzheimer's patients make up 10 percent of beneficiaries, they consume 20 percent of all Medicare spending.

What else do you want to know?

News Coverage

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Alzheimer's as a fiscal crisis

The hearing frames Alzheimer's not just as a medical issue, but as a primary driver of Medicare insolvency, shifting the policy conversation toward economic sustainability.

Connected Entities

Connie B. Karasow, Debbie Stabenow, Ronald C. Petersen and 4 more
PersonConnie B. Karasow“Caregiver”Map →
PersonDebbie Stabenow“U.S. Senator from Michigan”Map →
PersonRonald C. Petersen“Chair, Advisory Council on Research, Care, and Services”Map →
PersonPatrick J. Toomey“Chairman of the Subcommittee on Health Care”Map →
OrganizationMedicaid“Federal-state health assistance program”Map →
OrganizationMedicare“Federal health insurance program”Map →
PersonHenry L. Paulson“Director, Michigan Alzheimer's Disease Center”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance80
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record